anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Nuvectis Pharma · pitchdeck

Nuvectis Pharma | Investor Presentation Deck | 25 slides

25 pages · 5 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

Nuvectis Pharma | Investor Presentation Deck | 25 slides

Nuvectis Pharma · 2023-12
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON
Narrative range 15 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 3 slides 100% 3/3 slides 100% 3/3 slides · 14 hits
— 0/3 slides
66.7% 2/3 slides
— 0/3 slides
100% 3/3 slides 33.3% 1/3 slides Solution 6 slides 100% 6/6 slides 100% 6/6 slides · 29 hits
— 0/6 slides
— 0/6 slides
33.3% 2/6 slides 100% 6/6 slides 100% 6/6 slides Market Size 3 slides 100% 3/3 slides 100% 3/3 slides · 17 hits
— 0/3 slides
— 0/3 slides
— 0/3 slides
100% 3/3 slides
— 0/3 slides
Competition 2 slides 100% 2/2 slides 100% 2/2 slides · 10 hits
— 0/2 slides
100% 2/2 slides 100% 2/2 slides 100% 2/2 slides 100% 2/2 slides Financials 1 slides 100% 1/1 slides 100% 1/1 slides · 5 hits
— 0/1 slides
100% 1/1 slides
— 0/1 slides
100% 1/1 slides
— 0/1 slides

Slide inventory

25
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · Problem
02
other
Open slide detailBeat · Problem
03
summarize
Open slide detailBeat · ProblemLoop · Cost Of Inaction
04
The slide uses a split layout: team members on the left and their associated track record (logos) on the right.other
Open slide detailBeat · SolutionLoop · Cost Of Inaction
05
The slide uses a timeline-based pipeline layout to show the progression of two drug candidates.plan_implementation
Open slide detailBeat · SolutionLoop · Cost Of Inaction
06
transition
Open slide detailBeat · SolutionLoop · Cost Of Inaction
07
summarize
Open slide detailBeat · SolutionLoop · Cost Of Inaction
08
Includes a detailed biological pathway diagram created with BioRender.present_solution
Open slide detailBeat · SolutionLoop · Cost Of Inaction
09
The slide demonstrates superior tumor growth inhibition by NXP800 compared to Cisplatin in both resistant and sensitive models.show_traction
Open slide detailBeat · SolutionLoop · Cost Of Inaction
10
Includes a patient MRI, a schematic of the PDX study design, a line chart showing tumor volume over time, and photographic evidence of tumor size reduction.show_traction
Open slide detailBeat · Market Size
11
The slide presents preclinical efficacy data for NXP800 in specific genetic subtypes of endometrial cancer.show_traction
Open slide detailBeat · Market Size
12
Includes footnotes regarding NGS panels and weighted average calculations.size_opportunity
Open slide detailBeat · Market Size
13
The slide uses a split-column layout to contrast two phases of a clinical trial.plan_implementation
Open slide detailLoop · Quick Win Big Bet
14
transition
Open slide detailLoop · Quick Win Big Bet
15
summarize
Open slide detailLoop · Quick Win Big Bet
16
The charts are kinome dendrograms (KinomeScan style).compare_peers
Open slide detailBeat · CompetitionLoop · Quick Win Big Bet
17
The slide uses a structural biology mechanism of action (MOA) comparison to demonstrate competitive advantage.present_solution
Open slide detailBeat · CompetitionLoop · Quick Win Big Bet
18
Includes a biological pathway diagram, microscopy images, and an IC50 dose-response curve.present_solution
Open slide detailLoop · Quick Win Big Bet
19
The charts show tumor regression in NXP900 treated groups versus tumor growth in control groups over 27 days.show_traction
Open slide detailLoop · Quick Win Big Bet
20
Includes two distinct experimental setups: cell proliferation assays and mouse tumor growth models.present_solution
Open slide detailLoop · Quick Win Big Bet
21
The slide uses a structured table to segment market opportunity by biological markers.size_opportunity
Open slide detailLoop · Quick Win Big Bet
22
Clinical trial identifier NCT05873686 is provided.show_traction
Open slide detailLoop · Quick Win Big Bet
23
summarize
Open slide detailBeat · Financials
24
summarize
Open slide detail
25
front_matter
Open slide detail